{"target": "https://www.ncbi.nlm.nih.gov/research/pubtator-api/publications/export/biocjson?pmids=30031018", "sourcedb": "PubMed", "sourceid": "30031018", "text": "Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial. BACKGROUND AND AIMS: GERD patients frequently complain of regurgitation of gastric contents. Medical therapy with proton-pump inhibitors (PPIs) is frequently ineffective in alleviating regurgitation symptoms, because PPIs do nothing to restore a weak lower esophageal sphincter. Our aim was to compare effectiveness of increased PPI dosing with laparoscopic magnetic sphincter augmentation (MSA) in patients with moderate-to-severe regurgitation despite once-daily PPI therapy. METHODS: One hundred fifty-two patients with GERD, aged &gt;=21 years with moderate-to-severe regurgitation despite 8 weeks of once-daily PPI therapy, were prospectively enrolled at 21 U.S. sites. Participants were randomized 2:1 to treatment with twice-daily (BID) PPIs (N = 102) or to laparoscopic MSA (N = 50). Standardized foregut symptom questionnaires and ambulatory esophageal reflux monitoring were performed at baseline and at 6 months. Relief of regurgitation, improvement in foregut questionnaire scores, decrease in esophageal acid exposure and reflux events, discontinuation of PPIs, and adverse events were the measures of efficacy. RESULTS: Per protocol, 89% (42/47) of treated patients with MSA reported relief of regurgitation compared with 10% (10/101) of the BID PPI group (P &lt; .001) at the 6-month primary endpoint. By intention-to-treat analysis, 84% (42/50) of patients in the MSA group and 10% (10/102) in the BID PPI group met this primary endpoint (P &lt; .001). Eighty-one percent (38/47) of patients with MSA versus 8% (7/87) of patients with BID PPI had &gt;=50% improvement in GERD-health-related quality of life scores (P &lt; .001), and 91% (43/47) remained off of PPI therapy. A normal number of reflux episodes and acid exposures was observed in 91% (40/44) and 89% (39/44) of MSA patients, respectively, compared with 58% (46/79) (P &lt; .001) and 75% (59/79) (P = .065) of BID PPI patients at 6 months. No significant safety issues were observed. In MSA patients, 28% reported transient dysphagia; 4% reported ongoing dysphagia. CONCLUSION: Patients with GERD with moderate-to-severe regurgitation, especially despite once-daily PPI treatment, should be considered for minimally invasive treatment with MSA rather than increased PPI therapy. (Clinical trial registration number: NCT02505945.).", "project": "Standigm_training", "denotations": [{"id": "T0", "span": {"begin": 124, "end": 137}, "obj": "MPA"}, {"id": "T1", "span": {"begin": 141, "end": 145}, "obj": "DISEASE"}, {"id": "T10", "span": {"begin": 701, "end": 705}, "obj": "DISEASE"}, {"id": "T11", "span": {"begin": 750, "end": 763}, "obj": "MPA"}, {"id": "T12", "span": {"begin": 1102, "end": 1108}, "obj": "NEGREG"}, {"id": "T13", "span": {"begin": 1112, "end": 1125}, "obj": "MPA"}, {"id": "T14", "span": {"begin": 1127, "end": 1138}, "obj": "POSREG"}, {"id": "T15", "span": {"begin": 1142, "end": 1170}, "obj": "MPA"}, {"id": "T16", "span": {"begin": 1172, "end": 1180}, "obj": "NEGREG"}, {"id": "T17", "span": {"begin": 1184, "end": 1208}, "obj": "MPA"}, {"id": "T18", "span": {"begin": 1213, "end": 1226}, "obj": "MPA"}, {"id": "T19", "span": {"begin": 1228, "end": 1243}, "obj": "NEGREG"}, {"id": "T2", "span": {"begin": 199, "end": 203}, "obj": "DISEASE"}, {"id": "T22", "span": {"begin": 1367, "end": 1375}, "obj": "REG"}, {"id": "T23", "span": {"begin": 1376, "end": 1382}, "obj": "NEGREG"}, {"id": "T24", "span": {"begin": 1386, "end": 1399}, "obj": "DISEASE"}, {"id": "T27", "span": {"begin": 1750, "end": 1761}, "obj": "POSREG"}, {"id": "T28", "span": {"begin": 1765, "end": 1807}, "obj": "CPA"}, {"id": "T29", "span": {"begin": 1848, "end": 1851}, "obj": "NEGREG"}, {"id": "T3", "span": {"begin": 224, "end": 232}, "obj": "REG"}, {"id": "T30", "span": {"begin": 1887, "end": 1902}, "obj": "MPA"}, {"id": "T31", "span": {"begin": 1907, "end": 1921}, "obj": "MPA"}, {"id": "T32", "span": {"begin": 1926, "end": 1934}, "obj": "REG"}, {"id": "T35", "span": {"begin": 2162, "end": 2170}, "obj": "REG"}, {"id": "T36", "span": {"begin": 2181, "end": 2190}, "obj": "DISEASE"}, {"id": "T37", "span": {"begin": 2195, "end": 2203}, "obj": "REG"}, {"id": "T38", "span": {"begin": 2212, "end": 2221}, "obj": "DISEASE"}, {"id": "T39", "span": {"begin": 2249, "end": 2253}, "obj": "DISEASE"}, {"id": "T40", "span": {"begin": 2278, "end": 2291}, "obj": "MPA"}, {"id": "T5", "span": {"begin": 336, "end": 347}, "obj": "NEGREG"}, {"id": "T6", "span": {"begin": 363, "end": 376}, "obj": "MPA"}, {"id": "T7", "span": {"begin": 414, "end": 421}, "obj": "REG"}, {"id": "T9", "span": {"begin": 610, "end": 623}, "obj": "MPA"}, {"id": "T42", "span": {"begin": 236, "end": 249}, "obj": "MPA"}, {"id": "T43", "span": {"begin": 351, "end": 362}, "obj": "POSREG"}, {"id": "T44", "span": {"begin": 292, "end": 303}, "obj": "PROTEIN"}, {"id": "T45", "span": {"begin": 429, "end": 456}, "obj": "CPA"}, {"id": "T46", "span": {"begin": 424, "end": 428}, "obj": "NEGREG"}, {"id": "T47", "span": {"begin": 480, "end": 493}, "obj": "POSREG"}, {"id": "T48", "span": {"begin": 497, "end": 506}, "obj": "POSREG"}, {"id": "T49", "span": {"begin": 1018, "end": 1046}, "obj": "CPA"}, {"id": "T50", "span": {"begin": 64, "end": 75}, "obj": "PROTEIN"}, {"id": "T51", "span": {"begin": 91, "end": 101}, "obj": "REG"}], "relations": [{"id": "R10", "pred": "ThemeOf", "subj": "T24", "obj": "T23"}, {"id": "R11", "pred": "ThemeOf", "subj": "T28", "obj": "T27"}, {"id": "R12", "pred": "ThemeOf", "subj": "T30", "obj": "T32"}, {"id": "R13", "pred": "ThemeOf", "subj": "T31", "obj": "T32"}, {"id": "R15", "pred": "ThemeOf", "subj": "T36", "obj": "T35"}, {"id": "R16", "pred": "ThemeOf", "subj": "T38", "obj": "T37"}, {"id": "R2", "pred": "ThemeOf", "subj": "T13", "obj": "T12"}, {"id": "R3", "pred": "ThemeOf", "subj": "T15", "obj": "T14"}, {"id": "R4", "pred": "ThemeOf", "subj": "T17", "obj": "T16"}, {"id": "R5", "pred": "ThemeOf", "subj": "T18", "obj": "T16"}, {"id": "R8", "pred": "ThemeOf", "subj": "T23", "obj": "T22"}, {"id": "R17", "pred": "ThemeOf", "subj": "T0", "obj": "T1"}, {"id": "R18", "pred": "ThemeOf", "subj": "T3", "obj": "T42"}, {"id": "R19", "pred": "ThemeOf", "subj": "T3", "obj": "T2"}, {"id": "R20", "pred": "ThemeOf", "subj": "T5", "obj": "T43"}, {"id": "R21", "pred": "ThemeOf", "subj": "T6", "obj": "T43"}, {"id": "R22", "pred": "ThemeOf", "subj": "T7", "obj": "T46"}, {"id": "R23", "pred": "ThemeOf", "subj": "T45", "obj": "T46"}, {"id": "R24", "pred": "ThemeOf", "subj": "T48", "obj": "T47"}, {"id": "R25", "pred": "ThemeOf", "subj": "T40", "obj": "T39"}], "attributes": [], "modifications": [], "config": {"entity types": [{"id": "MPA", "default": true}, {"id": "DISEASE"}, {"id": "NEGREG"}, {"id": "POSREG"}, {"id": "REG"}, {"id": "CPA"}, {"id": "PROTEIN"}], "relation types": [{"id": "ThemeOf", "default": true}]}}